Eli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity ...

In a Phase 3 trial, Lilly found a weekly injection of retatrutide reduced moderate-to-severe obstructive sleep apnea severity ...

Studies in mice reveal a new target for potentially treating and preventing life-threatening cardiovascular complications in ...

Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced ...

Sleep apnea becomes substantially more severe on weekends compared to weekdays, and the effect is amplified in people who ...

Athens-Limestone Hospital introduces the FDA-approved Genio system to North Alabama, offering innovative nerve stimulation ...

A new study identifies the FXR bile receptor as a key therapeutic target to prevent sleep apnea cardiovascular complications.

Promising results in sleep apnea pill could eliminate patient need for uncomfortable CPAP machine - Leaving obstructive sleep ...

A large phase 3 clinical trial has revealed promising results for a once-nightly pill designed to treat obstructive sleep ...

Obstructive Sleep Apnea was called the 'Pickwickian syndrome' in the past because Joe, the fat boy, described in 'The Pickwick Papers' by Charles Dickens, had typical features such as snoring, obesity ...

Share on Pinterest Could obstructive sleep apnea affect a person’s cognitive function? Image credit: Enes Evren/Getty Images. Obstructive sleep apnea is the most common type of sleep-breathing ...

A pair of surgical scissors from the Ming Dynasty tomb of physician Xia Quan. (Ling et al., Antiquity, 2026) This Week In ...